Function of the c-Myc oncogenic transcription factor

被引:318
|
作者
Dang, CV [1 ]
Resar, LMS
Emison, E
Kim, S
Li, Q
Prescott, JE
Wonsey, D
Zeller, K
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
oncogene; transcription factor; c-Myc; cell cycle; metabolism; cell adhesion; apoptosis; immortalization;
D O I
10.1006/excr.1999.4686
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The c-myc gene and the expression of the c-Myc protein are frequently altered in human cancers. The c-myc gene encodes the transcription factor c-Myc, which heterodimerizes with a partner protein, termed Max, to regulate gene expression. Max also heterodimerizes with the Mad family of proteins to repress transcription, antagonize c-Myc, and promote cellular differentiation The constitutive activation of c-myc expression is key to the genesis of many cancers, and hence the understanding of c-Myc function depends on our understanding of its target genes. In this review, we attempt to place the putative target genes of c-Myc in the context of c-Myc-mediated phenotypes. From this perspective, c-Myc emerges as an oncogenic transcription factor that integrates the cell cycle machinery with cell adhesion, cellular metabolism, and the apoptotic pathways. (C) 1999 Academic Press.
引用
收藏
页码:63 / 77
页数:15
相关论文
共 50 条
  • [21] Direct activation of TERT transcription by c-MYC
    Kou-Juey Wu
    Carla Grandori
    Mario Amacker
    Nathalie Simon-Vermot
    Axel Polack
    Joachim Lingner
    Riccardo Dalla-Favera
    Nature Genetics, 1999, 21 : 220 - 224
  • [22] INVITRO INHIBITION OF C-MYC TRANSCRIPTION BY MITHRAMYCIN
    HARDENBOL, P
    VANDYKE, MW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (02) : 553 - 558
  • [23] BMI-1 COOPERATES WITH C-MYC, SUPPRESSES TRANSCRIPTION AND ATTENUATES C-MYC INDUCED APOPTOSIS
    COHEN, KJ
    HANNA, JS
    DANG, CV
    BLOOD, 1994, 84 (10) : A374 - A374
  • [24] MICROINJECTED C-MYC AS A COMPETENCE FACTOR
    KACZMAREK, L
    HYLAND, JK
    WATT, R
    ROSENBERG, M
    BASERGA, R
    SCIENCE, 1985, 228 (4705) : 1313 - 1315
  • [25] AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC
    Taira, T
    Maeda, J
    Onishi, T
    Kitaura, H
    Yoshida, S
    Kato, H
    Ikeda, M
    Tamai, K
    Iguchi-Ariga, SMM
    Ariga, H
    GENES TO CELLS, 1998, 3 (08) : 549 - 565
  • [26] ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX
    AMATI, B
    BROOKS, MW
    LEVY, N
    LITTLEWOOD, TD
    EVAN, GI
    LAND, H
    CELL, 1993, 72 (02) : 233 - 245
  • [27] THE MACROMOLECULAR STATE OF THE TRANSCRIPTION FACTOR E2F AND GLUCOCORTICOID REGULATION OF C-MYC TRANSCRIPTION
    RHEE, KS
    MA, TL
    THOMPSON, EA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (25) : 17035 - 17042
  • [28] Suppression of Aurora-A oncogenic potential by c-Myc downregulation
    Shangbin Yang
    Shun He
    Xiaobo Zhou
    Mei Liu
    Hongxia Zhu
    Yihua Wang
    Wei Zhang
    Shuang Yan
    Lanping Quan
    Jingfeng Bai
    Ningzhi Xu
    Experimental & Molecular Medicine, 2010, 42 : 759 - 767
  • [29] Suppression of Aurora-A oncogenic potential by c-Myc downregulation
    Yang, Shangbin
    He, Shun
    Zhou, Xiaobo
    Liu, Mei
    Zhu, Hongxia
    Wang, Yihua
    Zhang, Wei
    Yan, Shuang
    Quan, Lanping
    Bai, Jingfeng
    Xu, Ningzhi
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2010, 42 (11): : 759 - 767
  • [30] Rational design of a miniprotein to inhibit the oncogenic transcription factor MYC
    Ellenbroek, Brecht
    Kahler, Jan Pascal
    Arella, Damiano
    Lin, Cherina
    Jespers, Willem
    Pomplun, Sebastian
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30